US › Healthcare

MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

US · Healthcare · Drug Manufacturers - General

$0.68+9.95%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-1.2M
Profit YoY
+35.5%
EPS
$-0.03

Key statistics

Market cap
$33.3M
Forward P/E
0.0
P/B
3.56
Book value
$0.22
EPS (TTM)
$-1.27
52-week high
$2.45
52-week low
$0.60
50-day MA
$0.95
200-day MA
$1.21
Beta
1.49

Analyst view

Analysts rate MIRA Pharmaceuticals, Inc. Common Stock a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $17.75.

Shareholding

Insiders
30.58%
Institutions
5.07%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC1.65%
Cross Staff Investments Inc0.86%
Geode Capital Management, LLC0.69%
Vanguard Fiduciary Trust Co0.40%
BlackRock Inc0.27%
Suncoast Equity Management, LLC0.22%
Northern Trust Corp0.16%
First American Bank/Carpentersville IL0.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MIRA Pharmaceuticals, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.